Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The membrane-associated androgen receptor (mAR) is a functional class of cell-surface receptors that mediate rapid, non-genomic signaling in response to androgens such as testosterone and dihydrotestosterone (DHT). Unlike the classical nuclear androgen receptor (AR), which primarily functions as a ligand-activated transcription factor, mARs are localized to the plasma membrane—often within lipid rafts—and trigger immediate intracellular signaling cascades upon ligand binding [1, 3, 15]. Several distinct proteins have been identified as mARs, including the zinc transporter ZIP9 (SLC39A9), the G protein-coupled receptor GPRC6A, the oxoeicosanoid receptor 1 (OXER1), and the ion channel TRPM8, as well as specific splice variants of the classical AR like AR8 and AR45 [2, 6, 10]. These receptors play critical roles in various physiological and pathological processes, including the regulation of zinc and calcium levels, cell migration, and apoptosis [1, 15]. In the context of disease, mARs are significantly involved in the progression of hormone-dependent cancers, particularly prostate and breast cancer [4, 11]. They are often expressed or even upregulated in castration-resistant prostate cancer (CRPC), where they can sustain tumor growth and survival even when androgen levels are low or when the classical AR is inhibited [10, 12]. Because many mARs do not respond to conventional antiandrogens like bicalutamide or enzalutamide, they represent a novel frontier for therapeutic intervention [4, 12]. Current research focuses on developing specific inhibitors or utilizing mAR-mediated pathways to induce apoptosis in cancer cells, while also considering the potential safety concerns related to systemic zinc homeostasis and metabolic regulation [8, 15].
Non-genomic signaling through activation of intracellular kinase cascades (MAPK/ERK, PI3K/Akt), modulation of ion flux (calcium, zinc), and interaction with G proteins.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane-associated androgen receptor (mAR) (mAR).